Ying‐Bei Chen

Also affiliated with Kettering University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 28 papers. Top paper: “Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial”.

Everolimus plus bevacizumab is an effective first‐line treatment for patients with advanced papillary variant renal cell carcinoma: Final results from a phase II trial

Cancer(2020)10.1002/cncr.33148

N/A

1.2DataRank · unranked

38 citations

Yasser Ged, Chung‐Han Lee, Andrea Knežević, Ana M. Molina, Ying‐Bei Chen +13 more

Long-term Outcomes of Local and Metastatic Small Cell Carcinoma of the Urinary Bladder and Genomic Analysis of Patients Treated With Neoadjuvant Chemotherapy

Clinical Genitourinary Cancer(2022)10.1016/j.clgc.2022.05.005

N/A

0.937DataRank · unranked

33 citations

Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley Marie Regazzi, Timothy F. Donahue +25 more

Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy

Cancer Cell(2021)10.1016/j.ccell.2021.03.007

N/A

0.917DataRank · unranked

451 citations

Renzo G. DiNatale, Fengshen Kuo, Raghvendra M. Srivastava, Lynda Vuong, Diego Chowell +28 more

Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas

European Urology Focus(2022)10.1016/j.euf.2021.12.002

N/A

0.835DataRank · unranked

27 citations

Cerise Tang, Mark Zucker, Kelly N. Fitzgerald, Renzo G. DiNatale, Phillip M. Rappold +15 more

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma With Prognostic Implications

Modern Pathology(2024)10.1016/j.modpat.2024.100557

N/A

0.646DataRank · unranked

18 citations

Karissa Whiting, Min-Yuen Teo, Jacob E. Tallman, Gamze Gokturk Ozcan, Merve Başar +21 more

A Targetable Myeloid Inflammatory State Governs Disease Recurrence in Clear-Cell Renal Cell Carcinoma

Cancer Discovery(2022)10.1158/2159-8290.cd-21-0925

N/A

0.529DataRank · unranked

33 citations

Lynda Vuong, Josef Leibold, Nicholas H. Chakiryan, Michael Curry, Fengshen Kuo +31 more

Clinical Outcomes, Genomic Heterogeneity, and Therapeutic Considerations Across Histologic Subtypes of Urothelial Carcinoma

European Urology(2025)10.1016/j.eururo.2025.04.008

N/A

0.489DataRank · unranked

25 citations

Ziyu Chen, Karissa Whiting, Irina Ostrovnaya, Andrew T. Lenis, Timothy N. Clinton +26 more

Immunometabolic coevolution defines unique microenvironmental niches in ccRCC

Cell Metabolism(2023)10.1016/j.cmet.2023.06.005

N/A

0.483DataRank · unranked

24 citations

Amy Xie, Eric Minwei Liu, Fengshen Kuo, Min‐Soo Kim, Renzo G. DiNatale +15 more

L1 Cell Adhesion Molecule (L1CAM) Expression and Molecular Alterations Distinguish Low-Grade Oncocytic Tumor From Eosinophilic Chromophobe Renal Cell Carcinoma

Modern Pathology(2024)10.1016/j.modpat.2024.100467

N/A

0.464DataRank · unranked

21 citations

Jie‐Fu Chen, Achim A. Jungbluth, Sirma H. Koutzaki, Matthew B. Palmer, Hikmat Al‐Ahmadie +8 more

A Phase 2 Trial of Talazoparib and Avelumab in Genomically Defined Metastatic Kidney Cancer

European Urology Oncology(2023)10.1016/j.euo.2023.10.017

N/A

0.416DataRank · unranked

15 citations

Sahil D. Doshi, Andrea Knežević, Joshua Chaim, Ying‐Bei Chen, Rachel Jacobi +14 more

Neurofibromatosis Type 2-Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif Dual Immunohistochemistry Is a Reliable Marker for the Detection of Neurofibromatosis Type 2 Alterations in Diffuse Pleural Mesothelioma

Modern Pathology(2023)10.1016/j.modpat.2022.100030

N/A

0.396DataRank · unranked

13 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Large cell neuroendocrine carcinoma of the urothelial tract (LNEC): The MSKCC experience.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.4526

N/A

0.269DataRank · unranked

5 citations

Jatin Gandhi, Min Yuen Teo, Michael Lattanzi, Samuel A. Funt, David H. Aggen +14 more

Resource-efficient pooled sequencing expands translational impact in solid tumors

Kidney Cancer Journal(2021)10.52733/kcj18n2.a1

N/A

0.104DataRank · unranked

1 citations

Roy Mano, Vladimir Makarov, Nicole Rusk, Esther Drill, Andrew Winer +13 more

Pathologic Response to Immunotherapy is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

medRxiv(2025)10.1101/2025.04.24.25326353

N/A

0DataRank · unranked

0 citations

Stephen W. Reese, Burçin Ağrıdağ Üçpınar, Andrea Knežević, Lennert Eismann, Chih‐Ying Wu +14 more

TGF-β suppresses type 2 immunity to cancer

Nature(2020)10.1038/s41586-020-2836-1

N/A

0DataRank · unranked

189 citations

Fengshen Kuo, Kristelle J. Capistrano, Davina Kang, Briana G. Nixon, Wei Shi +11 more

Intratumoral early activated TCF1+ CD4 Th cells drive effector CD8 T cell responses in a novel sarcomatoid RCC model through anti-CTLA4 therapy 3951

The Journal of Immunology(2025)10.1093/jimmun/vkaf283.1692

N/A

0DataRank · unranked

0 citations

Lynda Vuong, Fengshen Kuo, Doris Zheng, Alex Penson, Jing Zhang +15 more

Genetic basis of SMARCB1 protein loss in 22 sinonasal carcinomas

Human Pathology(2020)10.1016/j.humpath.2020.08.004

N/A

0DataRank · unranked

28 citations

Paolo Cotzia, Ryan Ptashkin, Gouri J. Nanjangud, Bin Xu, Amir Momeni Boroujeni +7 more

TGFβ Suppresses Type 2 Immunity to Cancer

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.04.977629

N/A

0DataRank · unranked

0 citations

Fengshen Kuo, Kristelle J. Capistrano, Davina Kang, Briana G. Nixon, Wei Shi +11 more

Imaging features of fumarate hydratase-deficient renal cell carcinomas: a retrospective study

Cancer Imaging(2021)10.1186/s40644-021-00392-9

N/A

0DataRank · unranked

36 citations

Maria I. Carlo, Ying‐Bei Chen, Hebert Alberto Vargas, Ines Nikolovski

A pilot study of preoperative nivolumab in high-risk nonmetastatic renal cell carcinoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.323

N/A

0DataRank · unranked

5 citations

Kyrollis Attalla, Sujata Patil, Samuel Murray, Ying‐Bei Chen, Ritesh R. Kotecha +5 more

Resource-efficient pooled sequencing expands translational impact in solid tumors

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.06.447265

N/A

0DataRank · unranked

0 citations

Roy Mano, Vladimir Makarov, Nicole Rusk, Esther Drill, Andrew Winer +13 more

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma

Frontiers in Oncology(2022)10.3389/fonc.2022.910147

N/A

0DataRank · unranked

14 citations

Mark Zucker, Min‐Soo Kim, Paul Russo, Jonathan Coleman, Chung‐Han Lee +6 more

Molecular Characterization of the Tumor Microenvironment in Renal Medullary Carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.04.28.489873

N/A

0DataRank · unranked

2 citations

Mark Zucker, Min‐Soo Kim, Paul Russo, Jonathan Coleman, Chung‐Han Lee +6 more

Dual NF2-YAP/TAZ immunohistochemistry is a reliable marker for the detection of NF2 alterations in diffuse pleural mesothelioma

Research Square(2022)10.21203/rs.3.rs-1720495/v1

N/A

0DataRank · unranked

0 citations

Soo‐Ryum Yang, Ying‐Bei Chen, Prasad S. Adusumilli, Ann Bialik, Francis M. Bodd +9 more

Ganglioneuroblastoma intermixed: Clinicopathological implications of diagnosis at presentation and genomic correlations

Pediatric Blood & Cancer(2023)10.1002/pbc.30434

N/A

0DataRank · unranked

5 citations

Shakeel Modak, Fiorella Iglesias Cardenas, Judy Sarungbam, S. Joseph Sirintrapun, Anuradha Gopalan +6 more

Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.4559

N/A

0DataRank · unranked

0 citations

Andrew R. Schroeder, Semanti Mukherjee, Yelena Kemel, Ritesh R. Kotecha, Chung‐Han Lee +12 more

Pathologic Response to Immunotherapy Is Associated with Survival in Patients Undergoing Delayed Nephrectomy for Metastatic Renal Cell Carcinoma

European Urology Oncology(2025)10.1016/j.euo.2025.11.003

N/A

0DataRank · unranked

1 citations

Stephen W. Reese, Burçin Ağrıdağ Üçpınar, Andrea Knežević, Lennert Eismann, Chih‐Ying Wu +14 more

Immune Checkpoint Blockade Response in Mucinous Tubular and Spindle Cell Carcinoma

Current Oncology(2025)10.3390/curroncol32020094

N/A

0DataRank · unranked

1 citations

Neil J. Shah, Maria I. Carlo, Fengshen Kuo, A. Ari Hakimi, Ying‐Bei Chen +3 more